A reversed-phase high-performance liquid chromatography assay was developed and validated to determine plasma and brain lamotrigine concentrations allowing pharmacokinetic-pharmacodynamic studies of this new antiepileptic drug in patients and laboratory animals. Lamotrigine and its internal standard were extracted, under alkaline conditions, from plasma and brain homogenate, into ethyl acetate; brain proteins were previously precipitated with trichloroacetic acid. The method was linear between 0.1 and 15.0 mg / l for plasma, with a detection limit of 0.008 mg / l, and between 0.1 and 5.0 mg / l for brain homogenate, with a detection limit of 0.023 mg / l. The method proved to be simple, useful and appropriate, not only for clinical and experimental research, but also for routine monitoring of lamotrigine concentrations in patients.
Introduction
carbamazepine, in that any of these three drugs acts by blocking the voltage-dependent sodium channels Lamotrigine (LTG), an antiepileptic agent chemiand thus prolonging their inactivated state and cally unrelated to other anticonvulsants stabilising the presynaptic membrane. Consequently (phenyltriazine derivative), is a new generation an-LTG acts in particular to prevent the release of tiepileptic drug which has shown to be effective excitatory neurotransmitters [3, 4] . against partial and secondarily generalized tonicAlthough the use of LTG in clinical practice is clonic seizures either on adjunctive treatment in reasonably well tolerated by patients, the resulting patients with refractory epilepsy or when received as benefits of its administration are subject to a more monotherapy [1, 2] . The mechanism of action of LTG complex evaluation, given a considerable inter-pais, nevertheless, comparable to that of phenytoin and tient variability observed in relation to the dosage required to obtain an adequate therapeutic response.
There seems to exist a linear relationship between obtained; nevertheless, the way in which the serum concentration and the induced pharmacological reover time, to be able to establish the relationship sponse inter-relate remains unknown [2, 5] . The between the two types of curve [10] [11] [12] [13] [14] . possible sources of variability, in the light of current Several chromatographic methods for the determiknowledge regarding the kinetic profile of LTG, may nation of LTG concentration in human serum / plashave their origin in the transposition of the bloodma have been reported [6, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] . However, considbrain barrier and / or in the intrinsic variability associering the concentration ranges studied by these ated with its mechanism of action. Tentative target methods, they do not seem adequate for clinical ranges of 1-4 mg / l have been proposed, but subresearch as described, seeing that it requires not only sequent observations have indicated that some paa wide concentration range but also a very low limit tients may tolerate much higher therapeutic conof detection. On the other hand, in spite of its centrations (.10 mg / l) without clinical toxicity relevance for experimental research, very few meth- [2, 6] . Therefore, it seems evident that further studies ods exist for the determination of LTG simultaneousare required to assess the relationship between ly in various biological fluids, and only one of them plasma concentration and clinical effect of LTG.
has been proposed for the determination of LTG in Furthermore, although most views concerning blood and brain [30] . fundamental mechanisms of human epileptic pheTherefore, in the present paper, a sensitive and nomena derived from investigations carried out on specific reversed-phase high-performance liquid experimental animal models, research on patients chromatography (HPLC) method, with a wide conwith epilepsy is essential to validate the relevance of centration range, was developed and validated to those data. Nevertheless direct examination of the quantify LTG in plasma and in rat brain homogenate, epileptic human brain has become very feasible in making it suitable not only for clinical and exrecent years, experimental paradigms are severely perimental research, but also for therapeutic drug limited by ethical and logistical reasons. Thus, it monitoring. seems that both goals are best met by designing parallel investigations involving patients and experimental animals [7] .
Experimental
The investigation in patients is now facilitated by the new clinical techniques that exist in association 2.1. Reagents with the surgical treatment of epilepsy [7] . Longterm video electroencephalographic (VEEG) moniLamotrigine BW430C78 [3,5-diamino-6-(2,3-toring is one of those new tools, widely accepted as a dichlorophenyl)-1,2,4-triazine] and its internal stancornerstone of the advanced diagnostic, especially in dard (I.S.) BW725C78 [3,5-diamino-6-(2-methoxythe management of patients who are candidates for phenyl)-1,2,4-triazine] (structural analogue) referepilepsy surgery [8] . This technique of seizure ence materials were kindly provided by Wellcome recording is frequently associated with medication Research Laboratories (Cardiff, UK) ( Fig. 1) . Ethyl discontinuing, one of the strategies used to precipiacetate, methanol (HPLC grade), sodium chloride, tate seizures. Additionally, the use of laboratory sodium hydroxide, sodium phosphate monobasic and animals may improve the understanding of the sodium phosphate dibasic dihydrate, trichloroacetic relationship between drug in the blood and drug in acid and triethylamine were purchased from Merck the brain. In fact, by necessitating the crossing of the (Darmstadt, Germany). Human plasma was kindly blood-brain barrier in order to exercise its therapeuprovided by the Portuguese Oncology Institute blood tic effect, the basis for the interpretation of the bank (Coimbra, Portugal). plasma levels of LTG requires that these levels reflect the drug concentrations at the neuronal sites 2.2. Apparatus of action [9] . From this perspective, the neuropharmocokinetic characterization of LTG would neces-A BAS-480 Liquid Chromatograph equipped with sarily have to include a parallel study of the evolua PM-80 pump, a Rheodyne manual injector with a tion of concentrations in the blood and in the brain 50-ml loop, a BAS UV-116 UV-Vis detector and a
Calibration
A stock standard of lamotrigine (100 mg / l) was prepared by dissolving 10 mg of BW430C78 in 100 ml of methanol. An intermediate standard (10 mg / l) was prepared by diluting the stock standard (1:10) with plasma or rat brain homogenate. Another intermediate standard (1 mg / l) was prepared by diluting appropriately the 10 mg / l intermediate standard ( 
Extraction
Plasma sample extraction was based on the method presented by Fraser et al. [20] and Sallustio and Morris [26] . The plasma (1 ml) was introduced into a 10-ml glass tube and 100 ml of the 40 mg / l internal standard solution were added. After that, 1 ml of 2 M NaOH was added in order to assure that the whole LTG would be in the molecular form, the only form capable of passing into the organic phase. The sample was mixed briefly (10 s) by vortex and 5 ml of ethyl acetate were added. The tube was capped, vortexed for 10 s and then mixed on a horizontal shaker at 400 oscillations / min for 10 min BAS DA-5 Chromatography Control and Data Sysbefore centrifugation at 1585 g for a further 10 min tem Interface (all from Bioanalytical Systems, West at 158C. The upper organic layer was transferred to a Lafayette, IN, USA) were used for analysis.
clean 10-ml conical glass tube and evaporated to Chromatographic separation was carried out on a dryness under a stream of nitrogen in a heating block LiChrospher 100 RP-18 (5 mm) LiChroCART 125-4 at 458C. The residue was reconstituted with 200 ml (Merck) for 10 min. The mobile phase, consisting of of mobile phase and injected into the HPLC system. 35.0% methanol, 64.7% 0.1 M potassium dihydrogen For brain tissue preparation, the total rat brain was phosphate solution and 0.3% triethylamine, was removed and homogenized with a 5 ml / g physiologipumped at a flow-rate of 1.0 ml / min. The prepared cal buffer (phosphate buffer; pH 7.4) in a glass mobile phase was filtered through a 0.45-mm Millihomogenizer in an ice-cold bath. The homogenate (1 pore filter and degassed in an ultra-sonicator bath. ml) was inserted into a conical glass tube and 100 ml The elution was performed at room temperature. The of the 20 mg / l internal standard solution were added. detector was set at 306 nm.
For deproteinization, 100 ml of a 20% trichloroacetic acid solution were added followed by centrifugation or I.S. only by assaying five replicates for each at 1585 g for 10 min at 158C. The supernatant concentration on the same day [18, 19, 34] . obtained was transferred to a 10-ml glass tube and
In order to study the specificity of the present submitted to a liquid-liquid extraction into ethyl method, six independent blank human plasma and rat acetate after basification as described for plasma.
brain homogenate samples were subjected to the same sample processing and analysed. Because LTG 2.5. Validation is usually used in combination with other drugs in human therapy, for selectivity evaluation, several The method was validated according to the existpotential interfering drugs were studied using the ing information [31, 32] , consisting of the study of specified conditions: carbamazepine, phenytoin, valthe reliability parameters: linearity, sensitivity, preciproic acid, phenobarbital, primidone, vigabatrin, sion, accuracy, recovery, specificity, selectivity and gabapentine, clobazam, clonazepam, midazolam and stability.
paracetamol. The chromatograms obtained were The linearity was tested between 0.1 and 15.0 compared with the typical lamotrigine chromatomg / l for plasma and 0.1 and 5.0 mg / l for brain grams. homogenate analysis. For the inter-day assay the Stability samples were freshly prepared by adding standards were prepared over a 5-day period, while a known amount of LTG to a drug-free matrix and the intra-day assay was performed for 1 day by stored in a refrigerator (48C) and in a freezer analysing each concentration 5 times. Calibration (2258C). The evaluation was performed by assaying data were plotted as a graph of LTG:I.S. peak area five replicates on each day. ratio versus LTG concentration. The plot was subjected to a weighted linear regression analysis with the inverse of the concentration squared as the 3. Results weighting factor. The data obtained were used for the subsequent study of the validation parameters.
3.1. Chromatography, specificity and selectivity The limit of detection (LOD) and the limit of quantification (LOQ) of the analytical technique Typical chromatograms of human plasma and rat were determined through the following equation expressed in concentration, K takes the value of 3 for I.S. were 6.9 and 2.3 min, respectively. The lack of LOD and 10 for LOQ, as per the recommendation of response in blank plasma and brain homogenate was the International Union of Pure and Applied Chemisdemonstrated. The following drugs, usually used in try (IUPAC), b is the slope of the calibration plot, co-administration with lamotrigine, were shown not and an estimate of the standard deviation of the to interfere using the specified conditions: carbamazblank, S , is given by the standard deviation of the epine, phenytoin, valproic acid, phenobarbital, primi- Accuracy and precision distribution with (n22) degrees of freedom [33, 35] . This assessment revealed a highly significant good-A summary of the results on precision and accura- 2 2 ness of fit seeing that x ,x . cy as derived from the measured concentrations for exp tab
In plasma, the lowest LOD calculated was 0.008 the validation samples when using the plasma con-nominal and experimental concentrations also revealed no statistical difference between them (P. 0.05), which confirmed the accuracy of the method. For brain homogenate, the dispersion around the mean value did not exceed 15% coefficient of variation and 20% for LOD (precision), and the mean value was within 615% of the actual value (accuracy), as recommended by the Washington criteria [31] . The paired comparison between nominal and experimental concentrations also revealed no statistical difference between them (P.0.05), which also confirmed the accuracy of the method. A summary of the results on precision and accuracy as derived from the measured concentrations for the validation samples when using the brain homogenate concentration range between 0.1 and 5.0 mg / l is given in Table 2 .
Recovery
The mean recovery of lamotrigine from plasma in Table 3 ). The average recovery of the internal standard was 86.1469.26%. centration range between 0.1 and 15.0 mg / l is given For brain homogenate analysis between 0.1 and in Table 1 . The mean coefficients of variation were 5.0 mg / l, the mean recovery of lamotrigine was also 4.02% for intra-day and 6.97% for inter-day analyfound to be consistent over the evaluated concenses. The bias varied between 23.63 and 3.46% for tration range and was 87.16612.82% (mean6SD) the intra-day assay and 23.79 and 1.82% for the (Table 4 ). The average recovery of the internal inter-day assay. The paired comparison between standard was 75.2467.10%. Table 1 a Summary of precision (% C. V.) and accuracy (% bias) of the analytical method for lamotrigine determination in plasma (n530) phase HPLC system with very simple chromatographic conditions. A liquid-liquid extraction is performed before column separation. Relative short 3.5. Stability time analysis is required (10 min). The UV detection at 306 nm provides excellent specificity, eliminating Lamotrigine in plasma and in brain homogenate most of the interference from plasma and brain appeared to be stable when stored in a refrigerator homogenate. There was no chromatographic interfer-(48C) for 4 and 3 days, respectively. The study in the ence from other commonly administered anticonvulfreezer (2258C) was performed during a period of 8 sants.
The accuracy of the method at the low end of the Table 4 range was improved by using the appropriate weight- ple and effective way to homogenize the variance of lamotrigine concentration calculated was 0.008 mg / l, which was much lower than those reported in others
